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investigating the feasibility, efficacy and
safety of controller-free interactive digital
rehabilitation technology in an inpatient
stroke population: study protocol for a
randomized controlled trial’
M. L. Bird1*, J. Cannell2, M. L. Callisaya3, E. Moles2, A. Rathjen2, K. Lane2, A. Tyson1 and S. Smith4Unfortunately, the original version of this article [1] con-
tained an error. An acknowledgement was included
incorrectly.
Support for this trial was received from the National
Stroke Association (Australia). We have also recieved
funding to assit with publication costs from The
Tasmanian Health Organisation (North).
The correct acknowledgement can be found below:
Support for this trial was received from the National
Stroke Association (Australia). We have also received
funding to assist with publication costs from The
Tasmanian Health Service (Northern Region).
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